From: A prospective study on tumour response assessment methods after neoadjuvant endocrine therapy in early oestrogen receptor-positive breast cancer
Rad-TR type [n (%)]
MRI
USS
Path-TR [n (%)]
N/A
7 (7)
14 (13)
0 (0)
Complete
27 (26)
16 (15)
1 (1)
Partial
40 (38)
49 (47)
76 (72)
Stable disease
29 (27)
24 (23)
28 (27)
Progressive disease
2 (2)